Comparing two drugs for poor responders in double ovarian stimulation
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial compares dydrogesterone with a GnRH antagonist to see which works better for women with a low number of eggs (poor responders) who are undergoing two rounds of egg retrieval in one cycle. It may help improve outcomes for those with specific fertility challenges.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been classified as a Poseidon group 4 patient, meaning you have a low number of eggs and are under 35 or over 35 with a diminished ovarian reserve.
- You are planning to have double ovarian stimulation (two egg retrievals in one menstrual cycle).
- You do not have polycystic ovary syndrome (PCOS).
- You do not have endometriosis.
- You have no history of repeated miscarriages.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two methods to trigger final egg maturation in people undergoing IVF who have had poor response to fertility medications in past cycles. The goal is to improve egg quality and increase chances of successful pregnancy.
This trial tests whether doing two shorter rounds of hormone stimulation in one menstrual cycle (dual ovarian stimulation) leads to more live births than the usual two separate stimulation cycles for women who have a low egg reserve. The goal is to find a better way to help women who have had limited success with IVF.
This study compares two ways to prepare the ovaries for egg retrieval before IVF: using a progestin hormone or a GnRH antagonist. The goal is to see which method leads to more successful embryo transfers.
This study compares two methods of stimulating the ovaries before IVF: one using a standard hormone (hCG) and another using a different protocol. The goal is to see if the new method works as well as the standard one, while possibly being more cost-effective.
This study tests if a combination of two hormone drugs (follitropin alfa/lutropin alfa) works as well as another drug (hMG) for Japanese women with low LH and FSH levels who are doing in vitro fertilization (IVF). The goal is to help them produce eggs for pregnancy.
This trial compares two hormone protocols for women with a low number of eggs (poor ovarian responders) undergoing IVF where embryos are frozen for later transfer. It tests if a medication called drospirenone can improve egg retrieval compared to the standard approach.
Hear when a new Infertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.